Average Co-Inventor Count = 3.34
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alkermes Pharma Ireland Limited (10 from 160 patents)
2. Elan Pharma International Limited (10 from 80 patents)
20 patents:
1. 11717481 - Reduction of flake-like aggregation in nanoparticulate active agent compositions
2. 11253478 - Reduction of flake-like aggregation in nanoparticulate active agent compositions
3. 9974747 - Reduction of flake-like aggregation in nanoparticulate active agent compositions
4. 9974746 - Reduction of flake-like aggregation in nanoparticulate active agent compositions
5. 9974748 - Reduction of flake-like aggregation in nanoparticulate active agent compositions
6. 9345665 - Reduction of flake-like aggregation in nanoparticulate active agent compositions
7. 8652464 - Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
8. 8323641 - Nanoparticulate compositions having lysozyme as a surface stabilizer
9. 8309136 - In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions
10. 8236352 - Glipizide compositions
11. 7998507 - Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
12. 7763278 - Nanoparticulate polycosanol formulations and novel polycosanol combinations
13. 7695739 - In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions
14. 7459283 - Nanoparticulate compositions having lysozyme as a surface stabilizer
15. 7244451 - Methods of making nanoparticulate drug compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers